SAVANNAH LANPHER: Open Payments
NPI 1700399987 · ANKENY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 43 payments from 11 companies in 2025. Trend: 2023 $856 · 2024 $885 · 2025 $845
Food & beverage: $698Education: $147
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $269 |
| UCB, Inc. | 8 | $164 |
| ABBVIE INC. | 6 | $127 |
| Arcutis Biotherapeutics, Inc. | 3 | $67 |
| GENZYME CORPORATION | 3 | $61 |
| PFIZER INC. | 2 | $50 |
| Galderma Laboratories, L.P. | 2 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $30 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: TREMFYA, Bimzelx, SKYRIZI, Zoryve, DUPIXENT, NEMLUVIO, ILUMYA, EUCRISA.
Industry payments across IA — which companies pay providers there.
